Press & News
The next generation biopharmaceuticals
Press releases 2019
2019-11-15
Older press releases
2019-09-20
Affibody and GE Healthcare to Collaborate on Development of Affibody® PET Imaging Tracers
2019-08-23
Affibodys latest Press releases
2023-01-05
Positive Top-line Clinical Data for Izokibep in Hidradenitis Suppurativa
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)